The  XXIInd International Symposium on Medicinal Chemistry (EFMC-ISMC 2012) will be held in Berlin on September 2 - 6, 2012.
It will be organised jointly by the German Chemical Society (GDCh) Division of Medicinal Chemistry and the German Pharmaceutical Society (DPhG) Section of Pharmaceutical/Medicinal Chemistry, on behalf of the European Federation for Medicinal Chemistry (EFMC).
The EFMC-ISMC 2012 will continue its tradition and will cover drug discovery advances in all major therapeutic areas as well as the most recent advances in lead identification and optimization strategies, drug design and profiling technologies. Particular emphasis will be put on first time disclosures. ISMC 2012 will also illustrate the impact of the -omics and biomarker areas on the interfaces between chemistry, informatics, biology and experimental medicine.

REGISTER NOW AND SUBMIT YOUR ABSTRACTS:

All participants are invited to register and submit abstracts of scientific communications which will be peer-reviewed by the Organising Committee and published in the book of abstracts distributed to all symposium attendants.
Participants wishing to contribute a poster or oral communication should submit their abstract before April 2 via the abstract submission link on the website. The preference of oral and poster presentation should be indicated by the applicant during the submission process (please tick where appropriate on the form and select the related session). Out of the submitted proposals, a limited number of oral communications will be selected by the International Organising Committee.
Please be aware that abstract for posters (and not OC) can still be submitted after April 2 and until May 31, 2010 but with a handling fee of 50,00 €. Abstract submission is final as of June 1.


CONFIRMED SESSION TOPICS
Antibody-Drug Conjugates - Finally Ready for Prime Time? (ACS Session I) Antiinfectives and the Resistance Problem Challenges and Opportunities for Drug Metabolism in Drug Discovery and Preclinical Drug Development (AFMC Session) Chemical Biology Approaches in Drug Discovery Chemistry and Stem-cell Research - Small Molecule Modulation of Stem Cells for Regenerative Medicines Designing Better Drugs: Ligand Efficiency Guided Optimization in Drug Discovery (ACS Session II) Drug Safety: What Toxic Effects can be Reasonably Predicted? Emerging Drugs – Case Studies of Recently Disclosed New Medicines Epigenetics - An Area Offering Formidable Challenges and Opportunities for Medicinal Chemists Fighting Cancer : Kinases and Beyond First Time Disclosures Hot Trends in Process Chemistry Intractable Targets: is Bigger Better? Late Breaking News Metabolic Disorders Molecular Therapies for Inflammatory and Autoimmune Diseases New Developments in CNS Drug Research New Opportunities in Lead Discovery New Small Molecule Approaches for Neglected Diseases Next Generation of Cardiovascular Drugs Predictive Tools, Virtual Screening and Cheminformatics Recent Highlights in Medicinal Chemistry Strategies to Tackle Challenging Targets in Oncology Synthetic Chemistry: from Nano to Macro (EuCheMS Session) Targeting Protein-protein Interactions The impact of Transporters in Drug Discovery and Oral Bioavailability Enhancement (EUFEPS Session) What's New in GPCR Research?


AWARDS - CALL FOR NOMINATIONS
Several awards and prizes will be conferred on the occasion of the International Symposium on Medicinal Chemistry. More info on the awards and prizes as well as deadlines for submissions can be found on www.ismc2012.org

Full info can be found on www.ismc2012.org
We look forward to your active participation!
On behalf of Bernd CLEMENT (University Kiel, Germany) and Eckhard OTTOW (Bayer Pharma, Germany), Symposium Chairmen.
______________________________________________

XXIInd EFMC-ISMC Symposium Secretariat
LD Organisation sprl - Scientific Conference Producers
Rue Michel de Ghelderode 33/002 B - 1348 Louvain-la-Neuve, Belgium
Tel: +32 10 45 47 77 Fax: +32 10 45 97 19
secretariat@ISMC2012.org

______________________________________________